| Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association RD Brook, S Rajagopalan, CA Pope III, JR Brook, A Bhatnagar, ... Circulation 121 (21), 2331-2378, 2010 | 7042 | 2010 |
| Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association RD Brook, B Franklin, W Cascio, Y Hong, G Howard, M Lipsett, R Luepker, ... Circulation 109 (21), 2655-2671, 2004 | 2891 | 2004 |
| Air Pollution and Cardiovascular Disease: JACC State-of-the-Art Review S Rajagopalan, SG Al-Kindi, RD Brook Journal of the American College of Cardiology 72 (17), 2054-2070, 2018 | 1122 | 2018 |
| Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults RD Brook, JR Brook, B Urch, R Vincent, S Rajagopalan, F Silverman Circulation 105 (13), 1534-1536, 2002 | 1069 | 2002 |
| Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association RM Carey, DA Calhoun, GL Bakris, RD Brook, SL Daugherty, ... Hypertension 72 (5), e53-e90, 2018 | 1021 | 2018 |
| Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model Q Sun, A Wang, X Jin, A Natanzon, D Duquaine, RD Brook, ... Jama 294 (23), 3003-3010, 2005 | 970 | 2005 |
| Expert position paper on air pollution and cardiovascular disease DE Newby, PM Mannucci, GS Tell, AA Baccarelli, RD Brook, K Donaldson, ... European heart journal 36 (2), 83-93, 2015 | 863 | 2015 |
| Cardiovascular effects of air pollution RD Brook Clinical science 115 (6), 175-187, 2008 | 860 | 2008 |
| Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity Q Sun, P Yue, JA Deiuliis, CN Lumeng, T Kampfrath, MB Mikolaj, Y Cai, ... Circulation 119 (4), 538-546, 2009 | 817 | 2009 |
| Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes BA Ference, JG Robinson, RD Brook, AL Catapano, MJ Chapman, ... New England Journal of Medicine 375 (22), 2144-2153, 2016 | 794 | 2016 |
| Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the American Heart Association RD Brook, LJ Appel, M Rubenfire, G Ogedegbe, JD Bisognano, WJ Elliott, ... Hypertension 61 (6), 1360-1383, 2013 | 761 | 2013 |
| American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity and Metabolism … RD Brook, S Rajagopalan, CA Pope 3rd, JR Brook, A Bhatnagar, ... Circulation 121 (21), 2331-2378, 2010 | 749 | 2010 |
| Environmental determinants of cardiovascular disease: lessons learned from air pollution SG Al-Kindi, RD Brook, S Biswal, S Rajagopalan Nature Reviews Cardiology 17 (10), 656-672, 2020 | 611 | 2020 |
| Air pollution and cardiovascular disease BA Franklin, R Brook, CA Pope III Current problems in cardiology 40 (5), 207-238, 2015 | 603 | 2015 |
| Ambient PM2.5, O3, and NO2 Exposures and Associations with Mortality over 16 Years of Follow-Up in the Canadian Census Health and Environment Cohort … DL Crouse, PA Peters, P Hystad, JR Brook, A van Donkelaar, RV Martin, ... Environmental health perspectives 123 (11), 1180-1186, 2015 | 581 | 2015 |
| A joint ERS/ATS policy statement: what constitutes an adverse health effect of air pollution? An analytical framework GD Thurston, H Kipen, I Annesi-Maesano, J Balmes, RD Brook, K Cromar, ... European Respiratory Journal 49 (1), 2017 | 578 | 2017 |
| Insights into the mechanisms and mediators of the effects of air pollution exposure on blood pressure and vascular function in healthy humans RD Brook, B Urch, JT Dvonch, RL Bard, M Speck, G Keeler, M Morishita, ... Hypertension 54 (3), 659-667, 2009 | 570 | 2009 |
| Air pollution and type 2 diabetes: mechanistic insights S Rajagopalan, RD Brook Diabetes 61 (12), 3037-3045, 2012 | 553 | 2012 |
| Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial J Vestbo, JA Anderson, RD Brook, PMA Calverley, BR Celli, C Crim, ... The Lancet 387 (10030), 1817-1826, 2016 | 527 | 2016 |
| Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a … BA Ference, F Majeed, R Penumetcha, JM Flack, RD Brook Journal of the American College of Cardiology 65 (15), 1552-1561, 2015 | 485 | 2015 |
